Welcome to LookChem.com Sign In|Join Free
  • or
2-amino-6-chloro-9-(cyclohexyl)-9H-purine is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

247193-35-7

Post Buying Request

247193-35-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

247193-35-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 247193-35-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,4,7,1,9 and 3 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 247193-35:
(8*2)+(7*4)+(6*7)+(5*1)+(4*9)+(3*3)+(2*3)+(1*5)=147
147 % 10 = 7
So 247193-35-7 is a valid CAS Registry Number.

247193-35-7Relevant academic research and scientific papers

Synthetic routes to N-9 alkylated 8-oxoguanines; Weak inhibitors of the human DNA glycosylase OGG1

Mahajan, Tushar R.,Ytre-Arne, Mari Eknes,Str?m-Andersen, Pernille,Dalhus, Bj?rn,Gundersen, Lise-Lotte

, p. 15944 - 15965 (2015)

The human 8-oxoguanine DNA glycosylase OGG1 is involved in base excision repair (BER), one of several DNA repair mechanisms that may counteract the effects of chemo- and radiation therapy for the treatment of cancer. We envisage that potent inhibitors of OGG1 may be found among the 9-alkyl-8-oxoguanines. Thus we explored synthetic routes to 8-oxoguanines and examined these as OGG1 inhibitors. The best reaction sequence started from 6-chloroguanine and involved N-9 alkylation, C-8 bromination, and finally simultaneous hydrolysis of both halides. Bromination before N-alkylation should only be considered when the N-substituent is not compatible with bromination conditions. The 8-oxoguanines were found to be weak inhibitors of OGG1. 6-Chloro-8-oxopurines, byproducts in the hydrolysis of 2,6-halopurines, turned out to be slightly better inhibitors than the corresponding 8-oxoguanines.

Synthesis and in vitro evaluation of novel 2,6,9-trisubstituted purines acting as cyclin-dependent kinase inhibitors

Legraverend, Michel,Ludwig, Odile,Bisagni, Emile,Leclerc, Sophie,Meijer, Laurent,Giocanti, Nicole,Sadri, Ramin,Favaudon, Vincent

, p. 1281 - 1293 (2007/10/03)

Novel C-2, C-6, N-9 trisubstituted purines derived from the olomoucine/roscovitine lead structure were synthesized and evaluated for their ability to inhibit starfish oocyte CDK1/cyclin B, neuronal CDK5/p35 and erk1 kinases in purified extracts. Structure

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 247193-35-7